(CercleFinance.com) – The health and provident group Apicil announced on Friday that its planned takeover bid for Bluelinea, a specialist in home support for the elderly, would be made at a price of 1. 15 euro per title.
The offer represents a discount of almost 17% compared to the last share price, which had been suspended last week at a price of 1.38 euros.
In a press release, Apicil notes however that its offer represents a premium of 2.2% compared to the price preceding the announcement of the results of the capital increase and the principle of an offer, on July 15th.
On the occasion of the subscription to the capital increase of Bluelinea, the mutualist group says that it crossed the thresholds of 50% of the capital and voting rights to now control 56.6% of the capital and 52, 3% of voting rights.
In order to reflect changes in the shareholding structure, Bluelinea’s supervisory board is now made up of eight members, including four representatives of Apicol.
The quotation of Bluelinea, whose value has collapsed by 65% over the past year, should resume on Monday July 25.
Apicil has indicated that it does not intend to implement a squeeze-out following its offer.